To evaluate the clinical efficacy and safety of ablating renal cell carcinoma (RCC) by irreversible electroporation (IRE).
Fifteen patients (19 lesions) with RCC who underwent IRE were retrospectively reviewed.
To evaluate the clinical efficacy and safety of ablating renal cell carcinoma (RCC) by irreversible electroporation (IRE).
Fifteen patients (19 lesions) with RCC who underwent IRE were retrospectively reviewed.